Foundation President and CEO Testified Before Congress on Drug Research
| 1 min read

Robert J. Beall, Ph.D, president and CEO of the Cystic Fibrosis Foundation testified before the Small Business Committee of the U.S. House of Representatives today. He urged members of the committee to support research for rare diseases such as CF.

Specifically, Dr. Beall asked Congress to reauthorize the Small Business Innovation Research (SBIR) program, which provides grants to small biotech companies. And, he urged Congress to dedicate a portion of these grants for small companies interested in developing innovative drug research and development programs for CF and other rare diseases. Congress must reauthorize the SBIR program before it expires in September.

Share this article
Topics
About the CF Foundation | Public Policy | Research
Recent news
CF Foundation Establishes Health Equity Awards to Advance Research Toward Optimal Health Outcomes
News | 5 min read
CF Foundation Honors the Legacy of Joe O’Donnell
News | 4 min read
CF Foundation Invests up to $5M in Clarametyx Biosciences to Develop a New Anti-Bacterial Therapy 
News | 2 min read
You might also be interested in...
Stay up to date with The Foundation

Sign up for our newsletter to get all of the latest news from The Foundation right in your inbox.

Subscribe